Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Julphar
Farmers Insurance
Covington
Deloitte
Citi
Teva
Moodys
Dow
Novartis

Generated: October 23, 2017

DrugPatentWatch Database Preview

TAZTIA XT Drug Profile

« Back to Dashboard

What is the patent landscape for Taztia Xt, and when can generic versions of Taztia Xt launch?

Taztia Xt is a drug marketed by Actavis Labs Fl Inc and is included in one NDA.

The generic ingredient in TAZTIA XT is diltiazem hydrochloride. There are twenty-six drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the diltiazem hydrochloride profile page.

Summary for Tradename: TAZTIA XT

US Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list3
Bulk Api Vendors: see list50
Patent Applications: see list2,128
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TAZTIA XT at DailyMed

Pharmacology for Tradename: TAZTIA XT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Fl Inc
TAZTIA XT
diltiazem hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL075401-001Apr 10, 2003AB4RXNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl Inc
TAZTIA XT
diltiazem hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL075401-004Apr 10, 2003AB4RXNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl Inc
TAZTIA XT
diltiazem hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL075401-002Apr 10, 2003AB4RXNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl Inc
TAZTIA XT
diltiazem hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL075401-003Apr 10, 2003AB4RXNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl Inc
TAZTIA XT
diltiazem hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL075401-005Apr 10, 2003AB4RXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Argus Health
Dow
Citi
Colorcon
Julphar
Teva
Deloitte
Fuji
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot